You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SABS Disposition Disclosure
Kropotova Alexandra · SEC Form 4 · Filed Jun 26, 2026
Disposition
Reported value range
Not reported
Kropotova Alexandra Chief Medical Officer
SABS
SAB Biotherapeutics
SABS
Transaction date
Jun 25, 2026
Public filing date
Jun 26, 2026
Filing lag
Filed 1 day later
SABS daily price context
Close on/before transaction
$3.87
Jun 25, 2026
First close after public filing
$3.9
Jun 29, 2026
30-day return after filing
-11.79%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 988 shares
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0001193125-26-285722
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Sab Biotherapeutics, Inc. SABS Current | Disposition | Jun 25, 2026 | Not reported |